Patents by Inventor Geoffrey M. Jackson

Geoffrey M. Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140302494
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 9, 2014
    Applicant: Myriad Genetics, Incorporated
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Publication number: 20130280703
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 24, 2013
    Applicant: Myriad Genetics, Incorporated
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Publication number: 20090325238
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: May 15, 2009
    Publication date: December 31, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Publication number: 20090325237
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: May 15, 2009
    Publication date: December 31, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Publication number: 20090269814
    Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.
    Type: Application
    Filed: March 11, 2009
    Publication date: October 29, 2009
    Inventors: Patricia D. Murphy, Marga B. White, Mark B. Rabin, Sheri J. Olson, Matthew Yoshikawa, Geoffrey M. Jackson, Tara Eskandari, Brenda Schryer, Michael Park
  • Patent number: 5260911
    Abstract: A method of seismic surveying uses seismic waveguides in the earth. Seismic energy is transmitted from outside the waveguide and detected within the waveguide or vice-versa. Coupling of energy between the outside and the inside of the waveguide is effected by energy leakage at coupling sites where the waveguide departs from planarity. The method analyzes seismic signals to determine the position and nature of coupling sites and the propagation characteristics of the waveguide.
    Type: Grant
    Filed: May 28, 1991
    Date of Patent: November 9, 1993
    Inventors: Iain M. Mason, Geoffrey M. Jackson, Delman Lee, David S. R. Campbell, Charles C. Mosher